MSC Exosomes for Peripheral Neuropathy: What the Research Explores
Peripheral neuropathy — damage to the peripheral nerves that can cause pain, numbness, and weakness — is an area where regenerative approaches have attracted research interest. Mesenchymal stem cell (MSC)–derived exosomes are one such subject of investigation. This article summarizes what the research explores, without making any claim about treatment.
The regenerative rationale
MSC exosomes carry proteins, lipids, and microRNAs that participate in cell-to-cell signaling. Much of the interest in these vesicles comes from their paracrine activity — the idea that they may influence surrounding cells rather than replacing them. In preclinical models, researchers study how these signals relate to inflammation and tissue repair.
What preclinical research examines
Laboratory and animal studies in this field typically explore questions such as how MSC-derived vesicles interact with neuroinflammation, Schwann cell activity, and the microenvironment around injured nerves. These are early-stage, research-only investigations, and findings in cell culture or animal models do not establish safety or efficacy in humans.
Key Published Research
Every entry links to its PubMed record.
- Exploring the role of mesenchymal stem cell-derived exosomes in diabetic and chemotherapy-induced peripheral neuropathy. Mol Neurobiol, 2024. Review. (PubMed)
- Therapeutic potential of mesenchymal stem cell-derived exosomes as nanomedicine for peripheral nerve injury. Int J Mol Sci, 2024. Review. (PubMed)
- Advances in therapies using mesenchymal stem cells and their exosomes for treatment of peripheral nerve injury. Neural Regen Res, 2025. Review. (PubMed)
- Mesenchymal stem cell treatment for peripheral nerve injury: a narrative review. Neural Regen Res, 2021. Review. (PubMed)
- Advances in mesenchymal stem cells and their derivatives for promoting peripheral nerve regeneration. Burns Trauma, 2025. Review. (PubMed)
- Exosomes and their microRNA cargo: new players in peripheral nerve regeneration. Neurorehabil Neural Repair, 2018. Review. (PubMed)
Important limitations
It is essential to be clear: MSC exosomes are not an approved treatment for peripheral neuropathy or any other condition. Material supplied for research is research-use-only (RUO). Any decision about clinical relevance rests entirely with appropriately licensed professionals operating within applicable regulations.
Accessing research-grade material
Licensed physicians and research institutions can review the underlying literature in our Exosome Research Library and request characterized, documented material through the Physician Portal.
Research-use-only. This article is provided for research and educational purposes and is not intended to diagnose, treat, cure, or prevent any disease. MSC exosomes are not FDA-approved to treat peripheral neuropathy or any other condition.